Efficacy of pegylated interferon α-2a and α-2b in patients with genotype 1 chronic hepatitis C: a meta-analysis

BACKGROUND: Two formulations of Pegylated interferon (Peg-IFN) are on the market for treatment of chronic hepatitis C virus (HCV) infection. The purpose of this meta-analysis was to assess the efficacy of Peg-IFN α-2a versus Peg-IFN α-2b in combination with ribavirin in anti-human immunodeficiency v...

Descripción completa

Detalles Bibliográficos
Autores principales: Coppola, Nicola, Pisaturo, Mariantonietta, Tonziello, Gilda, Sagnelli, Caterina, Sagnelli, Evangelista, Angelillo, Italo F
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3556138/
https://www.ncbi.nlm.nih.gov/pubmed/23245594
http://dx.doi.org/10.1186/1471-2334-12-357

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3556138/
https://www.ncbi.nlm.nih.gov/pubmed/23245594
http://dx.doi.org/10.1186/1471-2334-12-357

Ejemplares similares